Orthofix Q1 2026: Strong Start, Bullish Outlook

Orthofix kicked off 2026 with a solid first quarter, reporting global net sales of $196.4 million, a 3% increase year-over-year. They maintained their full-year guidance of $850-$860 million, anticipating a 5.5% growth. Spine fixation led the growth with 6% globally and 4% in the U.S., driven by improved distributor alignment and their seven D navigation tech. Therapeutic Solutions grew by 5%, while limb reconstruction inched up by 3%, setting the stage for double-digit U.S. gains. The company is optimistic about their pipeline, including full-year runs from TrueLok Elevate and Fitbone, and the full launch of VIRATA in the second half. Adjusted EBITDA was $9.7 million, gross margins reached 70.7%, and cash stood at $120.9 million. Orthofix is confident in their consistent execution, cash flow, and converting innovations into tangible results, building momentum quarter by quarter. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a5a9073bb42fb4de